Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
47.84
-0.88 (-1.81%)
Feb 21, 2025, 4:00 PM EST - Market closed
Tarsus Pharmaceuticals Market Cap
Tarsus Pharmaceuticals has a market cap or net worth of $1.83 billion as of February 21, 2025. Its market cap has increased by 86.63% in one year.
Market Cap
1.83B
Enterprise Value
1.59B
1-Year Change
86.63%
Ranking
Category
Stock Price
$47.84
Market Cap Chart
Since the IPO on October 16, 2020, Tarsus Pharmaceuticals's market cap has increased from $308.14M to $1.83B, an increase of 493.48%. That is a compound annual growth rate of 50.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 1.83B | -13.60% |
| Dec 31, 2024 | 2.12B | 215.74% |
| Dec 29, 2023 | 670.37M | 71.44% |
| Dec 30, 2022 | 391.01M | -15.95% |
| Dec 31, 2021 | 465.23M | -44.60% |
| Dec 31, 2020 | 839.84M | 172.55% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |